In this study, we elucidate that these epigenetic alterations play a vital role in regulating PDK1 and identify the new regulation axis of EZH2/HDAC2/miR-148a/PDK1 in breast cancer progression and therapeutic resistance. Here, EZH2 is linked to breast cancer.